Publications by authors named "Jianzhen Lin"

Claim this Profile
L
Long-term outcomes of upfront pancreatectomy with venous resection for pancreatic cancer: a single-center, retrospective analysis.
Jianzhen Lin, Muyue Liu, Yuyu Tu, Kai Zhang, Pengfei Wu

Int J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications following upfront pancreatectomy with venous resection do not compromise adjuvant chemotherapy delivery and survival in pancreatic cancer.
Giampaolo Perri, Samuele Grandi, Muyue Liu, Riccardo Pellegrini, Jianzhen Lin

Langenbecks Arch Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Cell-Free DNA Fragmentomics-Based Model for Early Detection of Pancreatic Cancer.
Lingdi Yin, Cheng Cao, Jianzhen Lin, Zheng Wang, Yunpeng Peng

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bathing with 2% chlorhexidine gluconate versus routine care for preventing surgical site infections after pancreatic surgery: a single-centre randomized controlled trial.
Wen-Sen Chen, Jian-Zhen Lin, Kai Zhang, Xiao-Ping Fang, Rong Wang

Clin Microbiol Infect· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients.
Xu Yang, Bowen Chen, Yanyu Wang, Yunchao Wang, Junyu Long, Linzhi Zhang, Jianzhen Lin, Lingxiang Yu, Lin Zhou

Hepatol Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm.
Jianzhen Lin

Eur J Surg Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Researcher Li-Ming MA: Contributions to systematic acarology and entomology.
Jian-Zhen Lin

Zootaxa· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers.
Jinzhu Mao, Dongxu Wang, Junyu Long, Xu Yang, Jianzhen Lin

J Immunother Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma.
Jianzhen Lin, Songhui Zhao, Dongxu Wang, Yang Song, Yue Che

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational spectrum and precision oncology for biliary tract carcinoma.
Jianzhen Lin, Yinghao Cao, Xu Yang, Guangyu Li, Yang Shi, Lin Zhao

Theranostics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer.
Jianzhen Lin, Xinxin Peng, Kun Dong, Junyu Long, Xuejiao Guo

Nat Commun· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis.
Junyu Long, Shan Huang, Yi Bai, Jinzhu Mao, Anqiang Wang, Yu Lin, Jianzhen Lin

Brief Bioinform· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amniotic Membrane Extract Protects Islets From Serum-Deprivation Induced Impairments and Improves Islet Transplantation Outcome.
Zhaoming Yang, Xiaohang Li, Chengshuo Zhang, Ning Sun, Tingwei Guo, Jianzhen Lin, Jialin Zhang

Front Endocrinol (Lausanne)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers.
Xu Yang, Ying Hu, Keyan Yang, Dongxu Wang, Jianzhen Lin

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study.
Dongxu Wang, Xu Yang, Junyu Long, Jianzhen Lin, Jinzhu Mao

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in Viability and Function of Pancreatic Islets after Coculture with Mesenchymal Stromal Cells: A Systemic Review and Meta-Analysis.
Xiaohang Li, Hongxin Lang, Baifeng Li, Chengshuo Zhang, Ning Sun, Jianzhen Lin, Jialin Zhang

J Diabetes Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apatinib as non-first-line treatment in patients with Intrahepatic Cholangiocarcinoma.
Jinzhu Mao, Xu Yang, Jianzhen Lin, Xiaobo Yang, Dongxu Wang

J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
Fucun Xie, Yi Bai, Xu Yang, Junyu Long, Jinzhu Mao, Jianzhen Lin

Int Immunopharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy.
Jin Bian, Jianzhen Lin, Junyu Long, Xu Yang, Xiaobo Yang

Am J Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Xu Yang, Dongxu Wang, Jianzhen Lin, Xiaobo Yang, Haitao Zhao

Lancet Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma.
Jianzhen Lin, Xu Yang, Junyu Long, Songhui Zhao, Jinzhu Mao, Lin Zhao

Hepatobiliary Surg Nutr· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China.
Dong-Xu Wang, Xu Yang, Jian-Zhen Lin, Yi Bai, Jun-Yu Long

World J Gastroenterol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials.
Dongxu Wang, Xu Yang, Jianzhen Lin, Yi Bai, Junyu Long

Therap Adv Gastroenterol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western Patients.
Jingyu Cao, Jing Hu, Siqin Liu, Funda Meric-Bernstam, Reham Abdel-Wahab, Maolin Yan, Jianzhen Lin, Milind Javle

JCO Precis Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review.
Bo Hu, Jian-Zhen Lin, Xiao-Bo Yang, Xin-Ting Sang

Cell Prolif· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis